These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29376982)

  • 1. [The efficacy of prevention of postoperative cognitive dysfunction in cardiac surgeries with the use of the cerebrolysin].
    Polushin AY; Yanishevskiy SN; Maslevtsov DV; Krivov VO; Beskrovnaya OV; Molchan NS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):37-45. PubMed ID: 29376982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PREVENTION OF CEREBROVASCULAR MICRO-EMBOLIZATION DURING AORTA-CORONARY BYPASS UNDER CONDITIONS OF ARTIFICIAL BLOOD CIRCULATION.
    Radiushin D; Loskutov O
    Georgian Med News; 2019 Sep; (294):83-87. PubMed ID: 31687955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative Cognitive Dysfunction after Coronary Artery Bypass Grafting.
    Yuan SM; Lin H
    Braz J Cardiovasc Surg; 2019; 34(1):76-84. PubMed ID: 30810678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote ischemic preconditioning prevents deterioration of short-term postoperative cognitive function after cardiac surgery using cardiopulmonary bypass: results of a pilot investigation.
    Hudetz JA; Patterson KM; Iqbal Z; Gandhi SD; Pagel PS
    J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):382-8. PubMed ID: 25440646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebral dysfunction after coronary artery bypass graft surgery with cardiopulmonary bypass].
    Tsygan IV
    Voen Med Zh; 2013 Nov; 334(11):30-5. PubMed ID: 24611306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative Use of Erythromycin Reduces Cognitive Decline After Coronary Artery Bypass Grafting Surgery: A Pilot Study.
    Thomaidou E; Argiriadou H; Vretzakis G; Megari K; Taskos N; Chatzigeorgiou G; Anastasiadis K
    Clin Neuropharmacol; 2017; 40(5):195-200. PubMed ID: 28816833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postoperative cerebral dysfunction].
    Tsygan NV; Odinak MM; Khubulava GG; Tsygan VN; Peleshok AS; Andreev RV; Kurasov ES; Litvinenko IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(4):34-39. PubMed ID: 28617376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal damage biomarkers in the identification of patients at risk of long-term postoperative cognitive dysfunction after cardiac surgery.
    Kok WF; Koerts J; Tucha O; Scheeren TW; Absalom AR
    Anaesthesia; 2017 Mar; 72(3):359-369. PubMed ID: 27987229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of cerebral tissue oxygenation and postoperative cognitive dysfunction among patients undergoing coronary artery bypass grafting randomised to surgery with or without cardiopulmonary bypass*.
    Kok WF; van Harten AE; Koene BM; Mariani MA; Koerts J; Tucha O; Absalom AR; Scheeren TW
    Anaesthesia; 2014 Jun; 69(6):613-22. PubMed ID: 24750013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuropsychological outcomes after coronary artery bypass grafting].
    Benetis R; Girdauskas E; Kinduris S
    Medicina (Kaunas); 2004; 40 Suppl 1():30-4. PubMed ID: 15079097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative oxygen concentration and neurocognition after cardiac surgery: study protocol for a randomized controlled trial.
    Shaefi S; Marcantonio ER; Mueller A; Banner-Goodspeed V; Robson SC; Spear K; Otterbein LE; O'Gara BP; Talmor DS; Subramaniam B
    Trials; 2017 Dec; 18(1):600. PubMed ID: 29254495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Colforsin daropate does not affect the cerebral blood-flow in cardiac surgery patients under cardiopulmonary bypass].
    Goto K; Mizutani A; Shingu C; Hasegawa A; Hidaka S; Ito K; Iwasaka H; Noguchi T
    Masui; 2004 Apr; 53(4):385-90. PubMed ID: 15160663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term and long-term cognitive function and cerebral perfusion in off-pump and on-pump coronary artery bypass patients.
    Chernov VI; Efimova NY; Efimova IY; Akhmedov SD; Lishmanov YB
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):74-81. PubMed ID: 16337804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of two different glycemic management protocols on postoperative cognitive dysfunction in coronary artery bypass surgery].
    Kurnaz P; Sungur Z; Camci E; Sivrikoz N; Orhun G; Senturk M; Sayin O; Tireli E; Gurvit H
    Rev Bras Anestesiol; 2017; 67(3):258-265. PubMed ID: 28256333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of operative mortality in elderly patients undergoing coronary artery bypass grafting. Emphasis on the influence of internal mammary artery grafting on mortality and morbidity.
    He GW; Acuff TE; Ryan WH; Bowman RT; Douthit MB; Mack MJ
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):73-81. PubMed ID: 8028382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally Circulatory-Assisted On-Pump Beating Coronary Artery Bypass Grafting for Patients With Complex Conditions for Off-Pump Surgery.
    Mizuno T; Egi K; Sakai K; Oi K; Hachimaru T; Makita T; Oishi K; Arai H
    Artif Organs; 2017 Mar; 41(3):233-241. PubMed ID: 27782315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microemboli during coronary artery bypass grafting. Genesis and effect on outcome.
    Clark RE; Brillman J; Davis DA; Lovell MR; Price TR; Magovern GJ
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):249-57; discussion 257-8. PubMed ID: 7853878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of a randomized double-blind placebo-controlled trial of cerebrolysin].
    Vereshchagin NV; Suslina ZA; Timerbaeva SL; Kashina EM; Gnezditskiĭ VV; Maksimova MIu; Rebrova OIu; Smirnova IN
    Ter Arkh; 2001; 73(4):22-7. PubMed ID: 11494441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
    Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial.
    Poon W; Matula C; Vos PE; Muresanu DF; von Steinbüchel N; von Wild K; Hömberg V; Wang E; Lee TMC; Strilciuc S; Vester JC
    Neurol Sci; 2020 Feb; 41(2):281-293. PubMed ID: 31494820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.